Cite
HARVARD Citation
Bei, Y. et al. (2022). Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway. Drug development research. 83 (2), pp. 379-388. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bei, Y. et al. (2022). Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway. Drug development research. 83 (2), pp. 379-388. [Online].